News & Updates

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D
Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D
17 Dec 2023

Early albuminuria reduction with finerenone in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) is responsible for a huge proportion of the treatment effect against CKD progression and facilitates a modest amount of the effect against cardiovascular outcomes, reports a study.

Albuminuria reduction accounts for treatment effect on CKD outcomes in T2D
17 Dec 2023
Frailty highly prevalent among older hypertensive adults
Frailty highly prevalent among older hypertensive adults
15 Dec 2023

The prevalence of frailty among older outpatients with hypertension is high, but the agreement between various frailty tools is moderate to weak, according to a study.

Frailty highly prevalent among older hypertensive adults
15 Dec 2023